METHOTREXATE - IMPLICATIONS OF PHARMACOGENETICS IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	1041-1042
Journal	Annals of the rheumatic diseases
Volume	80
DOIs	https://doi.org/10.1136/annrheumdis-2021-eular.3749
Publication status	Published - Jun 2021

Access to Document

@article{fc5e2be7f8f9419aa7b0cb4b49884ffe,

title = "METHOTREXATE - IMPLICATIONS OF PHARMACOGENETICS IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS",

author = "{Pinheiro Torres}, R. and {Pimentel Dos Santos}, F. and J. Branco",

year = "2021",

month = jun,

doi = "10.1136/annrheumdis-2021-eular.3749",

language = "English",

volume = "80",

pages = "1041--1042",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - METHOTREXATE - IMPLICATIONS OF PHARMACOGENETICS IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS

AU - Pinheiro Torres, R.

AU - Pimentel Dos Santos, F.

AU - Branco, J.

PY - 2021/6

Y1 - 2021/6

U2 - 10.1136/annrheumdis-2021-eular.3749

DO - 10.1136/annrheumdis-2021-eular.3749

M3 - Meeting Abstract

SN - 0003-4967

VL - 80

SP - 1041

EP - 1042

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

ER -